Cite
HARVARD Citation
Gray, A. et al. (2022). Is cervical cancer screening with high-risk human papillomavirus testing superior (or at least as accurate) at detecting CIN3+ compared with screening with cytology?. Evidence-based practice. 25 (6), pp. 12-13. [Online].